Elephantiasis nostras of the lips: a case report.
Identifieur interne : 00BA89 ( Ncbi/Curation ); précédent : 00BA88; suivant : 00BA90Elephantiasis nostras of the lips: a case report.
Auteurs : T P Sollecito [États-Unis] ; S. Derossi ; J C Stewart ; D. Ettlin ; C. MowadSource :
- Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics [ 1079-2104 ] ; 1997.
Descripteurs français
- KwdFr :
- Adulte, Antibactériens (usage thérapeutique), Antiprurigineux (usage thérapeutique), Association de médicaments (usage thérapeutique), Clindamycine (usage thérapeutique), Diagnostic différentiel, Dicloxacilline (administration et posologie), Dicloxacilline (usage thérapeutique), Doxépine (usage thérapeutique), Femelle, Fibrose, Humains, Infections bactériennes, Lymphangite (microbiologie), Maladies de la lèvre (anatomopathologie), Maladies de la lèvre (traitement médicamenteux), Oedème (anatomopathologie), Pénicillines (usage thérapeutique), Récidive, Tissu conjonctif (anatomopathologie), Éléphantiasis (anatomopathologie), Éléphantiasis (traitement médicamenteux), Épiderme (anatomopathologie), Érythromycine (usage thérapeutique), Érythème (anatomopathologie), Études de suivi.
- MESH :
- administration et posologie : Dicloxacilline.
- anatomopathologie : Maladies de la lèvre, Oedème, Tissu conjonctif, Éléphantiasis, Épiderme, Érythème.
- microbiologie : Lymphangite.
- traitement médicamenteux : Maladies de la lèvre, Éléphantiasis.
- usage thérapeutique : Antibactériens, Antiprurigineux, Association de médicaments, Clindamycine, Dicloxacilline, Doxépine, Pénicillines, Érythromycine.
- Adulte, Diagnostic différentiel, Femelle, Fibrose, Humains, Infections bactériennes, Récidive, Études de suivi.
English descriptors
- KwdEn :
- Adult, Anti-Bacterial Agents (therapeutic use), Antipruritics (therapeutic use), Bacterial Infections, Clindamycin (therapeutic use), Connective Tissue (pathology), Diagnosis, Differential, Dicloxacillin (administration & dosage), Dicloxacillin (therapeutic use), Doxepin (therapeutic use), Drug Therapy, Combination (therapeutic use), Edema (pathology), Elephantiasis (drug therapy), Elephantiasis (pathology), Epidermis (pathology), Erythema (pathology), Erythromycin (therapeutic use), Female, Fibrosis, Follow-Up Studies, Humans, Lip Diseases (drug therapy), Lip Diseases (pathology), Lymphangitis (microbiology), Penicillins (therapeutic use), Recurrence.
- MESH :
- chemical , administration & dosage : Dicloxacillin.
- chemical , therapeutic use : Anti-Bacterial Agents, Antipruritics, Clindamycin, Dicloxacillin, Doxepin, Erythromycin, Penicillins.
- drug therapy : Elephantiasis, Lip Diseases.
- microbiology : Lymphangitis.
- pathology : Connective Tissue, Edema, Elephantiasis, Epidermis, Erythema, Lip Diseases.
- therapeutic use : Drug Therapy, Combination.
- Adult, Bacterial Infections, Diagnosis, Differential, Female, Fibrosis, Follow-Up Studies, Humans, Recurrence.
Abstract
Elephantiasis nostras (EN) is a clinical entity that usually presents as a persistent swelling of the lower extremities. It has been related to recurrent lymphangitis of bacterial origin that causes a fibrosis and thickening of both epidermal and connective tissue. Although very rare, EN has been previously reported in the lips. This is the first case reported in the oral medicine literature that describes EN involving the lips. We describe the clinical features and a differential diagnosis of the lip lesions and a treatment protocol to which this patient has responded. A diagnosis of EN should be entertained in patients with chronically edematous, scaling lip lesions.
PubMed: 9377195
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :004F62
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :004F62
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :004F62
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :00BA89
Links to Exploration step
pubmed:9377195Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Elephantiasis nostras of the lips: a case report.</title><author><name sortKey="Sollecito, T P" sort="Sollecito, T P" uniqKey="Sollecito T" first="T P" last="Sollecito">T P Sollecito</name><affiliation wicri:level="3"><nlm:affiliation>University of Pennsylvania School of Dental Medicine, Philadelphia, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>University of Pennsylvania School of Dental Medicine, Philadelphia</wicri:regionArea><placeName><settlement type="city">Philadelphie</settlement><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Derossi, S" sort="Derossi, S" uniqKey="Derossi S" first="S" last="Derossi">S. Derossi</name></author><author><name sortKey="Stewart, J C" sort="Stewart, J C" uniqKey="Stewart J" first="J C" last="Stewart">J C Stewart</name></author><author><name sortKey="Ettlin, D" sort="Ettlin, D" uniqKey="Ettlin D" first="D" last="Ettlin">D. Ettlin</name></author><author><name sortKey="Mowad, C" sort="Mowad, C" uniqKey="Mowad C" first="C" last="Mowad">C. Mowad</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1997">1997</date><idno type="RBID">pubmed:9377195</idno><idno type="pmid">9377195</idno><idno type="wicri:Area/PubMed/Corpus">004F62</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004F62</idno><idno type="wicri:Area/PubMed/Curation">004F62</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004F62</idno><idno type="wicri:Area/PubMed/Checkpoint">004F62</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004F62</idno><idno type="wicri:Area/Ncbi/Merge">00BA89</idno><idno type="wicri:Area/Ncbi/Curation">00BA89</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Elephantiasis nostras of the lips: a case report.</title><author><name sortKey="Sollecito, T P" sort="Sollecito, T P" uniqKey="Sollecito T" first="T P" last="Sollecito">T P Sollecito</name><affiliation wicri:level="3"><nlm:affiliation>University of Pennsylvania School of Dental Medicine, Philadelphia, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>University of Pennsylvania School of Dental Medicine, Philadelphia</wicri:regionArea><placeName><settlement type="city">Philadelphie</settlement><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Derossi, S" sort="Derossi, S" uniqKey="Derossi S" first="S" last="Derossi">S. Derossi</name></author><author><name sortKey="Stewart, J C" sort="Stewart, J C" uniqKey="Stewart J" first="J C" last="Stewart">J C Stewart</name></author><author><name sortKey="Ettlin, D" sort="Ettlin, D" uniqKey="Ettlin D" first="D" last="Ettlin">D. Ettlin</name></author><author><name sortKey="Mowad, C" sort="Mowad, C" uniqKey="Mowad C" first="C" last="Mowad">C. Mowad</name></author></analytic><series><title level="j">Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics</title><idno type="ISSN">1079-2104</idno><imprint><date when="1997" type="published">1997</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Anti-Bacterial Agents (therapeutic use)</term><term>Antipruritics (therapeutic use)</term><term>Bacterial Infections</term><term>Clindamycin (therapeutic use)</term><term>Connective Tissue (pathology)</term><term>Diagnosis, Differential</term><term>Dicloxacillin (administration & dosage)</term><term>Dicloxacillin (therapeutic use)</term><term>Doxepin (therapeutic use)</term><term>Drug Therapy, Combination (therapeutic use)</term><term>Edema (pathology)</term><term>Elephantiasis (drug therapy)</term><term>Elephantiasis (pathology)</term><term>Epidermis (pathology)</term><term>Erythema (pathology)</term><term>Erythromycin (therapeutic use)</term><term>Female</term><term>Fibrosis</term><term>Follow-Up Studies</term><term>Humans</term><term>Lip Diseases (drug therapy)</term><term>Lip Diseases (pathology)</term><term>Lymphangitis (microbiology)</term><term>Penicillins (therapeutic use)</term><term>Recurrence</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Antibactériens (usage thérapeutique)</term><term>Antiprurigineux (usage thérapeutique)</term><term>Association de médicaments (usage thérapeutique)</term><term>Clindamycine (usage thérapeutique)</term><term>Diagnostic différentiel</term><term>Dicloxacilline (administration et posologie)</term><term>Dicloxacilline (usage thérapeutique)</term><term>Doxépine (usage thérapeutique)</term><term>Femelle</term><term>Fibrose</term><term>Humains</term><term>Infections bactériennes</term><term>Lymphangite (microbiologie)</term><term>Maladies de la lèvre (anatomopathologie)</term><term>Maladies de la lèvre (traitement médicamenteux)</term><term>Oedème (anatomopathologie)</term><term>Pénicillines (usage thérapeutique)</term><term>Récidive</term><term>Tissu conjonctif (anatomopathologie)</term><term>Éléphantiasis (anatomopathologie)</term><term>Éléphantiasis (traitement médicamenteux)</term><term>Épiderme (anatomopathologie)</term><term>Érythromycine (usage thérapeutique)</term><term>Érythème (anatomopathologie)</term><term>Études de suivi</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Dicloxacillin</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term><term>Antipruritics</term><term>Clindamycin</term><term>Dicloxacillin</term><term>Doxepin</term><term>Erythromycin</term><term>Penicillins</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Dicloxacilline</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Maladies de la lèvre</term><term>Oedème</term><term>Tissu conjonctif</term><term>Éléphantiasis</term><term>Épiderme</term><term>Érythème</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis</term><term>Lip Diseases</term></keywords><keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Lymphangite</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Lymphangitis</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Connective Tissue</term><term>Edema</term><term>Elephantiasis</term><term>Epidermis</term><term>Erythema</term><term>Lip Diseases</term></keywords><keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en"><term>Drug Therapy, Combination</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Maladies de la lèvre</term><term>Éléphantiasis</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antibactériens</term><term>Antiprurigineux</term><term>Association de médicaments</term><term>Clindamycine</term><term>Dicloxacilline</term><term>Doxépine</term><term>Pénicillines</term><term>Érythromycine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Bacterial Infections</term><term>Diagnosis, Differential</term><term>Female</term><term>Fibrosis</term><term>Follow-Up Studies</term><term>Humans</term><term>Recurrence</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Diagnostic différentiel</term><term>Femelle</term><term>Fibrose</term><term>Humains</term><term>Infections bactériennes</term><term>Récidive</term><term>Études de suivi</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Elephantiasis nostras (EN) is a clinical entity that usually presents as a persistent swelling of the lower extremities. It has been related to recurrent lymphangitis of bacterial origin that causes a fibrosis and thickening of both epidermal and connective tissue. Although very rare, EN has been previously reported in the lips. This is the first case reported in the oral medicine literature that describes EN involving the lips. We describe the clinical features and a differential diagnosis of the lip lesions and a treatment protocol to which this patient has responded. A diagnosis of EN should be entertained in patients with chronically edematous, scaling lip lesions.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00BA89 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 00BA89 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Curation
|type= RBID
|clé= pubmed:9377195
|texte= Elephantiasis nostras of the lips: a case report.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:9377195" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |